Chimeric Therapies' Acquisition

Chimeric Therapies was acquired by ArQule on , .

Developer of bone marrow graft engineering to expand the use of safe and effective cellular grafts tailored to treat and cure diseases of the immune system and blood system.…

Articles about Chimeric Therapies' Acquisition: